These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3721712)

  • 1. An intravitreal cannula system: long-term follow-up study.
    Ishibashi T; Miki K; Patterson R; Ryan SJ
    Int Ophthalmol; 1986 Apr; 9(1):5-9. PubMed ID: 3721712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An indwelling cannula system for the primate eye.
    Miki K; Patterson R; Ryan SJ
    J Neurosci Methods; 1985 May; 13(3-4):267-79. PubMed ID: 4010336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraocular cannula for chronic drug delivery. Method and clinical observation.
    Miki K; Ohkuma H; Ryan SJ
    Int Ophthalmol; 1985 Sep; 8(3):121-7. PubMed ID: 4066156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraocular cannula for continuous, chronic drug delivery. Histopathologic observations and function.
    Miki K; Patterson R; Ryan SJ
    Arch Ophthalmol; 1985 May; 103(5):712-7. PubMed ID: 3994581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant.
    Kato A; Kimura H; Okabe K; Okabe J; Kunou N; Ogura Y
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):238-44. PubMed ID: 14691179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of an ocular microdialysis technique in rabbits with permanently implanted vitreous probes: systemic and intravitreal pharmacokinetics of fluorescein.
    Anand BS; Atluri H; Mitra AK
    Int J Pharm; 2004 Aug; 281(1-2):79-88. PubMed ID: 15288345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis.
    Jaffe GJ; Yang CS; Wang XC; Cousins SW; Gallemore RP; Ashton P
    Ophthalmology; 1998 Jan; 105(1):46-56. PubMed ID: 9442778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular toxicity of intravitreal clarithromycin.
    Unal M; Peyman GA; Liang C; Hegazy H; Molinari LC; Chen J; Brun S; Tarcha PJ
    Retina; 1999; 19(5):442-6. PubMed ID: 10546942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method for chronic drug infusion into the eye.
    Miki K; Ohkuma H; Ryan SJ
    Jpn J Ophthalmol; 1984; 28(2):140-6. PubMed ID: 6471605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intravitreal injection of high-dose bevacizumab in monkey eyes.
    Sakurai K; Akiyama H; Shimoda Y; Yoshida I; Kurabayashi M; Kishi S
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4905-16. PubMed ID: 19407010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis.
    Cheng CK; Berger AS; Pearson PA; Ashton P; Jaffe GJ
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):442-53. PubMed ID: 7843913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
    Li J; Lan B; Li X; Sun S; Lu P; Cheng L
    J Control Release; 2016 Dec; 243():78-85. PubMed ID: 27717742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravitreal administration of indomethacin on experimental subretinal neovascularization in the subhuman primate.
    Sakamoto T; Soriano D; Nassaralla J; Murphy TL; Oganesian A; Spee C; Hinton DR; Ryan SJ
    Arch Ophthalmol; 1995 Feb; 113(2):222-6. PubMed ID: 7864756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular properties of urokinase-derived antiangiogenic A6 peptide in rabbits.
    Koh HJ; Cheng L; Bessho K; Jones TR; Davidson MC; Freeman WR
    J Ocul Pharmacol Ther; 2004 Oct; 20(5):439-49. PubMed ID: 15650519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of enzymatic posterior vitreous detachment by intravitreal injection of hyaluronidase.
    Harooni M; McMillan T; Refojo M
    Retina; 1998; 18(1):16-22. PubMed ID: 9502276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helical intravitreal triamcinolone acetonide implant: a 6-month surgical feasibility study in rabbits.
    Mello-Filho PA; Guven D; Beeley NR; de Juan E; Erickson SR
    Ophthalmic Surg Lasers Imaging; 2009; 40(2):160-8. PubMed ID: 19320305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique.
    Macha S; Mitra AK
    Exp Eye Res; 2001 Mar; 72(3):289-99. PubMed ID: 11180978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular localization of sodium fluorescein. Effects of administration in rabbit and monkey.
    Grayson MC; Laties AM
    Arch Ophthalmol; 1971 May; 85(5):600-3 passim. PubMed ID: 4996602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.